KV
Krishna Vaddi
Founder, CEO & DirectorDr. Krishna Vaddi, D.V.M., Ph.D., also known as Kris, founded Prelude Therapeutics Incorporated and serves as its Chief Executive Officer and Director from February 2016. He has been its Chief Executive Officer and Director February 2016. From June 2014 to June 2016, Dr. Vaddi also served as Chief Executive Officer of Orsenix, LLC, a clinical stage biotechnology company. Dr. Vaddi previously held several roles at Incyte Corporation, most recently as Senior Advisor from June 2015 to June 2016 and Group Vice President from March 2010 to June 2015. Dr. Vaddi received a BVSc in Veterinary Medicine from Acharya N.G. Ranga Agricultural University in India and a Ph.D. in Pharmacology and Toxicology from the University of Florida.
Positions
- Company NamePrelude Therapeutics IncorporatedStock CodePRLDPositionFounder, CEO & DirectorColleagues
- PAPaul A. FriedmanIndependent Chairman of the Board
- BDBryant David LimCFO, Chief Legal Officer & Corporate Secretary
- PAPeggy A. ScherleChief Scientific Officer
- ACAimee CrombieSenior VP and Head of Strategic Planning & Operations
- MPMadhu PudipeddiSenior Vice President of Technical Operations
- DBDavid BonitaIndependent Director
- VSVictor SandorIndependent Director
- KDKatina DortonIndependent Directors
